Abcam (ABCZY) Stock Price, News & Analysis

Company Overview

Abcam plc, a life sciences company, researches, develops, and distributes biological reagents and tools for research, drug discovery, and diagnostics in the United States, China, Japan, Germany, the United Kingdom, and internationally. The company offers various research products, including primary and secondary antibodies; ELISA and matched antibody pairs; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; lysates; and multiplex assays. Its research products are used in the areas of cancer, cardiovascular, cell biology, developmental biology, epigenetics, nuclear signaling, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells. The company also offers diagnostic and therapeutic solutions. The company also sells its products online. Abcam plc has partnership with Cancer Research UK for the development and commercialization of novel custom antibodies to support the acceleration of cancer research. Abcam plc was founded in 1998 and is headquartered in Cambridge, the United Kingdom.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 5,400 shs
• Average Volume: 4,712 shs
• Market Capitalization: $3.98 billion
• P/E Ratio: N/A
• Dividend Yield: 0.36%
• Price Target: N/A
• Consensus Rating: N/A

ABCZY Stock Analysis - Frequently Asked Questions

Does Abcam have any subsidiaries?

The following companies are subsidiaries of Abcam: Abcam Trading (Shanghai) Co. Ltd., Abcam US Group Holdings Inc., Abcam (US) Ltd., and Epitomics Inc.

How do I buy shares of Abcam?

Shares of ABCZY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Industrial Inorganic Chemicals
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:ABCZY
• Previous Symbol: NASDAQ:ABCZY
• CIK: N/A
• Web: www.abcam.com
• Phone: 44 1223 696 000
• Fax: N/A
• Employees: 1,750
• Year Founded: 1998

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $336.37 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 205,080,000
• Free Float: N/A
• Market Cap: $3.98 billion
• Optionable: Not Optionable
• Beta: 1.29